Search Results - "Asaji, Naoki"

Constitution of mucosa‐associated microbiota in the lower digestive tract does not change in early stage of non‐alcoholic fatty liver disease with fecal dysbiosis by Asaji, Naoki, Inoue, Jun, Hayashi, Hiroki, Tokunaga, Eri, Shimamoto, Yusaku, Kinoshita, Masato, Tanaka, Takeshi, Sakai, Arata, Yano, Yoshihiko, Ueda, Yoshihide, Kodama, Yuzo

“…Background and Aim Regarding the gut–liver axis, fecal dysbiosis is implicated in the pathogenesis of non‐alcoholic fatty liver disease (NAFLD). The…”
Get full text

Liver abscess caused by Cutibacterium namnetense after transarterial chemoembolization for hepatocellular carcinoma by Yasutomi, Eiichiro, Ueda, Yoshihide, Asaji, Naoki, Yamamoto, Atsushi, Yoshida, Ryutaro, Hatazawa, Yuri, Hayashi, Hiroki, Shiomi, Yuuki, Yano, Yoshihiko, Kodama, Yuzo

“…A 72-year-old man underwent transarterial chemoembolization (TACE) for solitary hepatocellular carcinoma (HCC) located on the S6 segment. He had a history of…”
Get full text

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma by Yano, Yoshihiko, Yamamoto, Atsushi, Mimura, Takuya, Kushida, Saeko, Hirohata, Seiya, Yoon, Seitetsu, Hirano, Hirotaka, Kim, Soo Ki, Hatazawa, Yuri, Momose, Kenji, Hayashi, Hiroki, Kado, Takuo, Nishi, Katsuhisa, Tanaka, Hidenori, Matsuura, Takanori, Yoshida, Ryutaro, Asaji, Naoki, Yasutomi, Eiichiro, Shiomi, Yuuki, Minami, Akihiro, Komatsu, Shohei, Fukumoto, Takumi, Ueda, Yoshihide, Kodama, Yuzo

“…Background and Aim The purpose of this study was to analyze factors associated with the overall survival (OS) of atezolizumab/bevacizumab combination therapy…”
Get full text

Easy and effective counter-traction using a clip with a looped thread for colorectal endoscopic submucosal dissection by Indo, Naohiko, Anami, Takahiro, Asaji, Naoki, Urakami, Satoshi, Nishio, Akihiro, Kitamura, Yasuaki, Watanabe, Akihiko

Get more information

Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers by Yamamoto, Atsushi, Yano, Yoshihiko, Ueda, Yoshihide, Yasutomi, Eiichiro, Hatazawa, Yuri, Hayashi, Hiroki, Yoshida, Ryutaro, Asaji, Naoki, Shiomi, Yuuki, Tobimatsu, Kazutoshi, Sakai, Arata, Kodama, Yuzo

“…Purpose The risk factors and clinical characteristics of ICI-induced immune-mediated hepatotoxicity (IMH) are not fully understood. Thus, the present study…”
Get full text

Acid‐treated high‐amylose corn starch suppresses high‐fat diet‐induced steatosis by Yoshida, Ryutaro, Yano, Yoshihiko, Hoshi, Namiko, Okamoto, Norihiro, Sui, Yunlong, Yamamoto, Atsushi, Asaji, Naoki, Shiomi, Yuuki, Yasutomi, Eiichiro, Hatazawa, Yuri, Hayashi, Hiroki, Ueda, Yoshihide, Kodama, Yuzo

“…ABSTRACT Resistant starch (RS) has been reported to improve steatosis as well as obesity. Type 4 resistant starch (RS4), a chemically modified starch, is…”
Get full text